2024 ASCO Annual Meeting
2024 ASCO Annual Meeting
Oral Abstract Session
Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology
Primary Track: Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology
June 1 – 3:00 PM CDT
location_onHall D1
2024 ASCO Annual Meeting
Rapid Oral Abstract Session
Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology
Primary Track: Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology
June 3 – 8:00 AM CDT
location_onS406
Dendrimer-enhanced (DEP) SN38 (DEP irinotecan) in patients (pts) with advanced solid tumors: A phase 1/2 trial.
8:12 AM CDTJia (Jenny) Liu, MD, PhDAbstract 3014
[IMG] 2024 ASCO Annual Meeting 2024 ASCO Annual Meeting Oral...
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
0.007(7.14%) |
Mkt cap ! $43.29M | |||
| Open | High | Low | Value | Volume |
| 9.5¢ | 10.5¢ | 9.5¢ | $8.154K | 83.09K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5102 | 9.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 124847 | 3 |
View Market Depth
| Last trade - 16.10pm 11/07/2024 (20 minute delay) ? |
| SPL (ASX) Chart |